A detailed history of Turning Point Benefit Group, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Turning Point Benefit Group, Inc. holds 3,397 shares of BSX stock, worth $348,837. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,397
Previous 3,821 11.1%
Holding current value
$348,837
Previous $410 Million 20.66%
% of portfolio
0.2%
Previous 0.31%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$97.03 - $108.14 $41,140 - $45,851
-424 Reduced 11.1%
3,397 $326 Million
Q2 2025

Jul 30, 2025

BUY
$89.7 - $107.41 $19,285 - $23,093
215 Added 5.96%
3,821 $410 Million
Q1 2025

May 12, 2025

BUY
$89.38 - $106.18 $30,836 - $36,632
345 Added 10.58%
3,606 $330 Million
Q4 2024

Feb 03, 2025

BUY
$83.62 - $91.5 $272,684 - $298,381
3,261 New
3,261 $309 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Turning Point Benefit Group, Inc. Portfolio

Follow Turning Point Benefit Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Turning Point Benefit Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Turning Point Benefit Group, Inc. with notifications on news.